Arizona State Retirement System’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,071
Closed -$314K 2068
2025
Q4
$314K Buy
+8,071
New +$260K ﹤0.01% 1732
2025
Q1
Sell
-7,599
Closed -$203K 2106
2024
Q4
$203K Buy
7,599
+47
+0.6% +$1.43K ﹤0.01% 1954
2024
Q3
$215K Buy
+7,552
New +$192K ﹤0.01% 1928
2022
Q2
Sell
-5,471
Closed -$245K 2260
2022
Q1
$245K Buy
5,471
+52
+1% +$2.15K ﹤0.01% 1915
2021
Q4
$232K Sell
5,419
-41
-0.8% -$2.14K ﹤0.01% 2002
2021
Q3
$363K Buy
5,460
+77
+1% +$5.42K ﹤0.01% 1716
2021
Q2
$395K Buy
5,383
+109
+2% +$7.2K ﹤0.01% 1714
2021
Q1
$361K Buy
5,274
+1,849
+54% +$139K ﹤0.01% 1718
2020
Q4
$230K Buy
+3,425
New +$186K ﹤0.01% 1875

Other funds holding CSTL

Arizona State Retirement System's CSTL Position: Q1 2026 in Review

Arizona State Retirement System sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 8,071 shares — an estimated $314K sold.

Arizona State Retirement System first reported a position in CSTL in Q4 2020 and held it in 9 quarters. The position peaked at $395K in Q2 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Arizona State Retirement System reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • Arizona State Retirement System sold 8,071 Castle Biosciences shares in Q1 2026, an estimated $314K.
  • Arizona State Retirement System first reported a position in Castle Biosciences in Q4 2020 and held it in 9 quarters.
  • Arizona State Retirement System's Castle Biosciences position peaked at $395K in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.